Why Do I Keep Getting UTIs After Menopause?

Menopause can change your urinary health, too

As estrogen falls, tissues in and around the vagina and urinary tract can become thinner and drier. The changes may bring burning, urgency, discomfort with sex or more frequent urinary infections. Clinicians group these symptoms under the name genitourinary syndrome of menopause, often shortened to GSM.

That does not mean every urinary symptom is an infection. Hormone-related irritation can feel similar, and more than one problem can be present. Knowing which problem you have helps you and your clinician choose the right treatment.

Sources: 1

First, find out what keeps coming back

A urine test can help establish whether symptoms come from an infection. A culture identifies bacteria and can help guide antibiotic choices. Your history matters alongside the result: when symptoms started, how often they return and whether treatment helped.

Tell your clinician if burning or urgency continues even when testing does not show an infection. You may need an assessment for another cause, rather than another course of antibiotics.

Before your visit, write down the dates of recent episodes, any urine-culture results, the medicines you took and what happened afterward. Mention vaginal dryness or discomfort with sex, too. You do not need to decide which detail is relevant before bringing it up.

Sources: 1, 2, 3

Ask about preventing the next infection

For some women with recurring UTIs during or after the menopause transition, a clinician may recommend low-dose vaginal estrogen. It can help restore protective vaginal bacteria and reduce the chance of another infection.

This is a prevention conversation. Vaginal estrogen does not replace treatment for a current bacterial infection, which may require antibiotics. Whether it belongs in your plan depends on your diagnosis and health history.

Bring a list of your medicines, hormones and any treatments you have already tried. If estrogen is recommended, ask which product to use, exactly how to use it and when to review whether the plan is helping. If you find the application uncomfortable or difficult, say so; that is part of making a treatment usable.

Sources: 3

A new study asked where the cream needs to go

The TAPER trial, published online in Obstetrics & Gynecology in July 2026, enrolled 114 postmenopausal women with recurrent UTIs. It compared twice-weekly estradiol cream inside the vagina with half that amount applied around the urethral opening, where urine leaves the body.

At six months, about 51% in the urethral-application group and 53% in the vaginal-application group remained UTI-free. The alternative approach met the researchers’ prespecified threshold for being no worse by more than an accepted margin.

That finding needs context. The margin was wide: 25 percentage points. The study was small, conducted at one center and not blinded. Participants averaged 71 years old, and most were White. Both groups received estrogen, so this trial cannot tell us how either approach compares with using none.

It offers a question to discuss if application is a barrier. It does not prove that the approaches are equivalent for every woman or justify changing the amount or placement of prescription cream yourself.

Sources: 4

Know which symptoms need prompt help

Contact a health professional for new urinary symptoms. Fever, chills, pain in your back or side, or nausea and vomiting alongside urinary symptoms can signal a kidney infection and need prompt medical attention.

An infection with new confusion, trouble breathing or rapidly worsening illness needs emergency assessment. Sepsis is a life-threatening response to infection. Do not wait for a routine appointment if you may be seriously ill.

Sources: 5, 6

Where does heart health fit?

Recurring bladder infections do not, on their own, mean you have heart disease. The connection that deserves attention is a history of serious illness such as sepsis.

A large observational study linked hospitalization with sepsis to a higher rate of later cardiovascular hospitalizations. It did not prove that sepsis caused those events, and it did not study ordinary recurrent bladder infections. The estrogen-cream trial did not test whether treatment prevents sepsis, heart attacks or strokes.

If you have been hospitalized with sepsis, keep that history and your discharge follow-up plan visible at future visits. For recurring UTIs, the immediate goal is clear: confirm what is causing the symptoms, treat the current problem and ask about a plan to reduce the next one.

Sources: 4, 7